Brochure
29 Oct 2016
Company Profile and Product Portfolio
PDF 35 kB
Content provided by our supplier
Murli Krishna Pharma Pvt Ltd
-
IN -
2016On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Other Content from Murli Krishna Pharma Pvt Ltd (2)
-
News Murli Krishna Pharma Pvt at CPHI North America
We are pleased announce we are participating in CPHI North America 2019. -
Video Nab Paclitaxel (Albumin Bound)
Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance